Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
27 May, 2018 15:00 IST
Panacea Biotec receives EIR for oncology manufacturing facility
Source: IRIS | 12 Mar, 2018, 10.40AM
Comments  |  Post Comment

Panacea Biotec announced the receipt of Establishment Inspection Report (EIR) from the U.S. Food & Drug Administration ('USFDA') indicating the formal closure of the Inspection conducted by USFDA, at its Pharmaceutical Formulation Facility for Oncology Parenteral and Oral Solids Dosage at Malpur, Baddi, District Solan, Himachal Pradesh, India.

Shares of the company gained Rs 9.7, or 3.45%, to trade at  Rs 290.75.  The total volume of shares traded  was  12,527 at the BSE (10.29 a.m., Monday).



Panacea Biotec Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Sun Pharmaceutical Industries quarterly earnings up 7% - 25-May-2018 16:12
Tech Mahindra quarterly profit zooms 2.09 times to Rs 12.31 bn - 25-May-2018 16:02
Lupin submits MAA for Etanercept Biosimilar in Europe - 25-May-2018 12:35
HDFC Sec maintains 'Buy' on Granules India - 25-May-2018 11:37
Zydus Cadila gets USFDA nod for Dutasteride, Tamsulosin HCl capsules - 25-May-2018 11:05
Pidilite Industries quarterly earnings surge 57.43% - 25-May-2018 10:34
United Breweries quarterly earnings soar 13.51 times - 25-May-2018 10:23
Larsen & Tubro bags order worth Rs 31.91 bn - 25-May-2018 09:57
MCX strengthens precious metals suite with launch of silver options - 24-May-2018 17:54
Granules India quarterly earnings plummet 55% - 24-May-2018 17:04
GAIL (India) quarterly profit zooms 3.92 times - 24-May-2018 16:58
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer